References with Clinical Peptides

2020

2020

  • Peptide Pools For Target Antigen Identification, Immune Monitoring, and Cellular Therapy
    A.Castro et al., Cytotherapy (2020) - PMID: n.a.
Archive

Archive

  • Autologous Adoptive T-Cell Therapy for Recurrent or Drug-Resistant Cytomegalovirus Complications in Solid Organ Transplant Patients: A Single-Arm Open-Label Phase I Clinical Trial
    Smith et al., Infectious Diseases Society of America (2016) - PMID: 29982441
  • Human Parainfluenza Virus-3 Can be Targeted by Rapidly Ex Vivo Expanded T Lymphocytes
    McLaughlin et al., Cytotherapy (2016) - PMID: 27692559
  • Peptide‐Stimulated Expansion of Virus‐Specific T Cells for Preventative Treatment After Allogeneic Stem Cell Transplantation
    Gary et al., AppNote (2015) - PMID: n.a.
  • Broadly-Specific Cytotoxic T Cells Targeting Multiple HIV Antigens Are Expanded From HIV+ Patients: Implications for Immunotherapy
    Lam et al., Molecular Therapy (2015) - PMID: 25366030
  • Expanded Cytotoxic T-Cell Lymphocytes Target the Latent HIV Reservoir
    Sung et al., Journal of Infectious Diseases (2015) - PMID: 25589335
  • Ex vivo Expansion of Human T cells for Adoptive Immunotherapy Using the Novel Xeno-free CTS Immune Cell Serum Replacement
    Smith et al., Clinical & Translational Immunology (2015) - PMID: 25671129
  • PepMixes to Generate Multiviral CTLS with Broad Specificity
    Leen et al., US Patent 20,150,010,519 (2015)
  • Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma
    Krishnadas et al., Pediatrics. (2013) - PMID: 23266925
  • QIMR Berghofer Medical Research Institute Selects JPT’s GxP PepMix™ Peptide Pool Technology to Support its Phase I/II Clinical Trials of Adoptive Immunotherapy for Human Cytomegalovirus-associated Diseases
    Press Release (2014)
  • Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections After HSCT
    Papadopoulou et al., Sci Transl Med. (2014) - PMID: 24964991
  • Immunotherapeutic Strategies to Prevent and Treat Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation
    Gerdemann et al. (2013) - PMID: 23152545
  • Rapidly Generated Multivirus-specific Cytotoxic T lymphocytes for the Prophylaxis and Treatment of Viral Infections
    Gerdemann et al., Mol Ther. (2012) - PMID: 22801446
  • LMP-Specific T-Cells for Patients With Relapsed EBV-Positive Lymphoma (ALCI)
    Bollard et al. (2012) - PMID: n.a
  • Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma
    Gerdemann et al., Molecular Therapy (2011) - PMID: 21915103
  • Cytotoxic T Lymphocyte Therapy with Donor T Cells Prevents and Treats Adenovirus and Epstein-Barr Virus Infections after Haploidentical and Matched Unrelated Stem Cell Transplantation
    Leen et al., Blood (2009) - PMID: 19700662
Loading...